Prefrontal Cortical Gamma-Aminobutyric Acid Levels in Panic Disorder Determined by Proton Magnetic Resonance Spectroscopy

Biological Psychiatry

Volumn 65, Issue 3, 2009, Pages 273-275

  Hasler, Gregor ^a   van der Veen, Jan Willem ^b   Geraci, Marilla ^b   Shen, Jun ^b   Pine, Daniel ^b   Drevets, Wayne C ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Anxiety disorders; depression; gamma aminobutyric acid; glutamate; MRS

Indexed keywords

4 AMINOBUTYRIC ACID; CHOLINE; CREATINE; GLUTAMIC ACID; N ACETYLASPARTIC ACID;

ADULT; AGORAPHOBIA; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; COMORBIDITY; CONTROL GROUP; CREATINE KINASE BLOOD LEVEL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; GRAY MATTER; HUMAN; INFORMED CONSENT; MALE; PANIC; PATIENT SELECTION; PHOBIA; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RADIOFREQUENCY;

ADOLESCENT; ADULT; ASPARTIC ACID; BRAIN CHEMISTRY; CHOLINE; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; OCCIPITAL LOBE; PANIC DISORDER; PREFRONTAL CORTEX; PSYCHIATRIC STATUS RATING SCALES; YOUNG ADULT;

EID: 58149301402     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2008.06.023     Document Type: Article

References (20)

1. Charney D.S., and Drevets W.C. The neurobiological basis of anxiety disorders. In: Davis K.L., Charney D.S., Coyle J.T., and Nemeroff C.B. (Eds). Neuropsychopharmacology: The Fifth Generation of Progress (2002), Lippincott Williams & Wilkins, Philadelphia 901-930
2. Goddard A.W., Mason G.F., Almai A., Rothman D.L., Behar K.L., Petroff O.A., et al. Reductions in occipital cortex GABA levels in panic disorder detected with 1h-magnetic resonance spectroscopy. Arch Gen Psychiatry 58 (2001) 556-561
3. Ham B.J., Sung Y., Kim N., Kim S.J., Kim J.E., Kim D.J., et al. Decreased GABA levels in anterior cingulate and basal ganglia in medicated subjects with panic disorder: A proton magnetic resonance spectroscopy (1H-MRS) study. Prog Neuropsychopharmacol Biol Psychiatry 31 (2007) 403-411
4. Ende G., Braus D.F., Walter S., Weber-Fahr W., Soher B., Maudsley A.A., and Henn F.A. Effects of age, medication, and illness duration on the N-acetyl aspartate signal of the anterior cingulate region in schizophrenia. Schizophr Res 41 (2000) 389-395
5. Sijens P.E., den Heijer T., Origgi D., Vermeer S.E., Breteler M.M., Hofman A., and Oudkerk M. Brain changes with aging: MR spectroscopy at supraventricular plane shows differences between women and men. Radiology 226 (2003) 889-896
6. Hasler G, Nugent AC, Carlson PJ, Carson RE, Geraci M, Drevets WC (in press): Altered cerebral GABAA-benzodiazepine receptor binding in panic disorder determined by [11C]flumazenil PET.Arch Gen Psychiatry.
7. Hasler G., van der Veen J.W., Tumonis T., Meyers N., Shen J., and Drevets W.C. Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch Gen Psychiatry 64 (2007) 193-200
8. Sailasuta N., LeRoux P., Hurd R., Wang P., Sachs N., and Ketter T. Detection of cerebral gamma-aminobutyric acid (GABA) in bipolar disorder patients and healthy volunteers at 3T. Proc Intl Soc Magn Reson Med 9 (2001) 1011
9. Hasler G., Neumeister A., van der Veen J.W., Tumonis T., Bain E.E., Shen J., et al. Normal prefrontal gamma-aminobutyric acid levels in remitted depressed subjects determined by proton magnetic resonance spectroscopy. Biol Psychiatry 58 (2005) 969-973
10. Massana G., Gasto C., Junque C., Mercader J.M., Gomez B., Massana J., et al. Reduced levels of creatine in the right medial temporal lobe region of panic disorder patients detected with (1)H magnetic resonance spectroscopy. Neuroimage 16 (2002) 836-842
11. Hetherington H.P., Mason G.F., Pan J.W., Ponder S.L., Vaughan J.T., Twieg D.B., and Pohost G.M. Evaluation of cerebral gray and white matter metabolite differences by spectroscopic imaging at 4.1T. Magn Reson Med 32 (1994) 565-571
12. Kreis R., Ernst T., and Ross B.D. Absolute quantification of water and metabolites in the human brain: II. Metabolite concentrations. J Magn Reson B 102 (1993) 9-19
13. Sanacora G., Mason G.F., Rothman D.L., Behar K.L., Hyder F., Petroff O.A., et al. Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry 56 (1999) 1043-1047
14. Shen J., Rothman D.L., and Brown P. In vivo GABA editing using a novel doubly selective multiple quantum filter. Magn Reson Med 47 (2002) 447-454
15. Epperson C.N., O'Malley S., Czarkowski K.A., Gueorguieva R., Jatlow P., Sanacora G., et al. Sex, GABA, and nicotine: The impact of smoking on cortical GABA levels across the menstrual cycle as measured with proton magnetic resonance spectroscopy. Biol Psychiatry 57 (2005) 44-48
16. Epperson C.N., Haga K., Mason G.F., Sellers E., Gueorguieva R., Zhang W., et al. Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: A proton magnetic resonance spectroscopy study. Arch Gen Psychiatry 59 (2002) 851-858
17. Goddard A.W., Mason G.F., Appel M., Rothman D.L., Gueorguieva R., Behar K.L., and Krystal J.H. Impaired GABA neuronal response to acute benzodiazepine administration in panic disorder. Am J Psychiatry 161 (2004) 2186-2193
18. Bhagwagar Z., Wylezinska M., Taylor M., Jezzard P., Matthews P.M., and Cowen P.J. Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor. Am J Psychiatry 161 (2004) 368-370
19. Sanacora G., Gueorguieva R., Epperson C.N., Wu Y.T., Appel M., Rothman D.L., et al. Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch Gen Psychiatry 61 (2004) 705-713
20. Petroff O.A. GABA and glutamate in the human brain. Neuroscientist 8 (2002) 562-573